266 related articles for article (PubMed ID: 28339036)
1. FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
Huang T; Wang L; Liu D; Li P; Xiong H; Zhuang L; Sun L; Yuan X; Qiu H
Int J Oncol; 2017 May; 50(5):1501-1512. PubMed ID: 28339036
[TBL] [Abstract][Full Text] [Related]
2. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
3. FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
Huang T; Liu D; Wang Y; Li P; Sun L; Xiong H; Dai Y; Zou M; Yuan X; Qiu H
Cell Physiol Biochem; 2018; 50(4):1332-1345. PubMed ID: 30355943
[TBL] [Abstract][Full Text] [Related]
4. Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling.
Chen G; Qiu H; Ke SD; Hu SM; Yu SY; Zou SQ
World J Gastroenterol; 2013 Apr; 19(16):2481-91. PubMed ID: 23674849
[TBL] [Abstract][Full Text] [Related]
5. FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547.
Xie L; Su X; Zhang L; Yin X; Tang L; Zhang X; Xu Y; Gao Z; Liu K; Zhou M; Gao B; Shen D; Zhang L; Ji J; Gavine PR; Zhang J; Kilgour E; Zhang X; Ji Q
Clin Cancer Res; 2013 May; 19(9):2572-83. PubMed ID: 23493349
[TBL] [Abstract][Full Text] [Related]
6. FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells.
Ropiquet F; Huguenin S; Villette JM; Ronflé V; Le Brun G; Maitland NJ; Cussenot O; Fiet J; Berthon P
Int J Cancer; 1999 Jul; 82(2):237-43. PubMed ID: 10389758
[TBL] [Abstract][Full Text] [Related]
7. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
Zhou H; Wu J; Wang T; Zhang X; Liu D
Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
[TBL] [Abstract][Full Text] [Related]
8. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
Park J; Kim SY; Kim HJ; Kim KM; Choi EY; Kang MS
Oncotarget; 2016 May; 7(19):28670-83. PubMed ID: 27107424
[TBL] [Abstract][Full Text] [Related]
9. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.
Matsuda Y; Ishiwata T; Yamahatsu K; Kawahara K; Hagio M; Peng WX; Yamamoto T; Nakazawa N; Seya T; Ohaki Y; Naito Z
Cancer Lett; 2011 Oct; 309(2):209-19. PubMed ID: 21745712
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hypermethylation of the FGFR2 gene in human gastric cancer cell lines.
Park S; Kim JH; Jang JH
Biochem Biophys Res Commun; 2007 Jun; 357(4):1011-5. PubMed ID: 17459342
[TBL] [Abstract][Full Text] [Related]
13. Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression.
Xu Y; Yang X; Li Z; Li S; Guo S; Ismail S; Liu H; Huang Z; Zhang Z; Chen Y; Sun Q
Oncotarget; 2017 Jan; 8(3):4888-4900. PubMed ID: 28002800
[TBL] [Abstract][Full Text] [Related]
14. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
[TBL] [Abstract][Full Text] [Related]
16. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4.
Yang ZY; Jiang H; Qu Y; Wei M; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Carcinogenesis; 2013 Dec; 34(12):2851-60. PubMed ID: 23803695
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer.
Shen K; Yu W; Yu Y; Liu X; Cui X
Biomed Pharmacother; 2018 Aug; 104():576-581. PubMed ID: 29803169
[TBL] [Abstract][Full Text] [Related]
18. miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer.
Yu Y; Yu X; Liu H; Song Q; Yang Y
Int J Mol Med; 2018 Aug; 42(2):998-1007. PubMed ID: 29786108
[TBL] [Abstract][Full Text] [Related]
19. PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.
Wang G; Zhang Q; Song Y; Wang X; Guo Q; Zhang J; Li J; Han Y; Miao Z; Li F
Cell Death Dis; 2015 Mar; 6(3):e1682. PubMed ID: 25766321
[TBL] [Abstract][Full Text] [Related]
20. FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.
Turczyk L; Kitowska K; Mieszkowska M; Mieczkowski K; Czaplinska D; Piasecka D; Kordek R; Skladanowski AC; Potemski P; Romanska HM; Sadej R
Neoplasia; 2017 Oct; 19(10):791-804. PubMed ID: 28869838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
